Evonik Industries AG

Evonik is one of the world’s leading specialty chemicals companies. Active in more than 100 countries and with about 32,000 employees, Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers.

Evonik provides a wide range of biomaterial solutions for the medical device market. Our portfolio includes ENDEXO® surface modification technology that enhances the biocompatibility of medical devices, and RESOMER®, a biodegradable polymer known for its excellent biocompatibility, controlled degradation, and customizable properties. Our highly tunable, non-animal derived VECOLLAN® collagen platform is produced through a sustainable fermentation-based process, and can be used for a range of medical applications. Evonik’s VESTAKEEP® grades for medical devices are changing standards for medical technology applications due to their outstanding biocompatibility and biostability.

Our expertise in the medical technology sector allows us to provide tailored solutions to meet the specific needs of customers. With a focus on innovation and sustainability, Evonik is committed to advancing the field of medical technology.

Evonik provides the technical capabilities and access to cGMP facilities that medical device innovators need to drive novel biomaterial concepts to market. By leveraging decades of market leadership for bioresorbable polymers and with a global team of experts, Evonik has created an extensive portfolio of next-generation products, technologies, and services that can support medical device companies during each stage of the product lifecycle.